Breach of competition law can give rise to substantial fines and reputational damage, and since the pharmaceutical sector continues to be under the spotlight of competition authorities, it's never been more important for companies to understand the risks.
What conduct are regulators interested in? How will Brexit have an impact on the application of the rules? What actions should your company be considering to ensure that competition law empowers your business, not hinder it?
Join us to discuss the key principles of competition law, the main competition cases in this sector and what companies should do to minimise any exposure.